Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma

被引:0
|
作者
Cihan, Yasemin Benderli [1 ]
机构
[1] Kayseri Educ & Res Hosp, Dept Radiat Oncol, Ataturk Blvd,Hastane St 78, TR-38010 Kayseri, Turkey
关键词
BODY RADIATION-THERAPY;
D O I
10.1007/s00345-018-2323-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1797 / 1798
页数:2
相关论文
共 50 条
  • [1] Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma
    Yasemin Benderli Cihan
    World Journal of Urology, 2018, 36 : 1797 - 1798
  • [2] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
  • [3] Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada
    Amdahl, J.
    Diaz, J.
    Park, J.
    Nakhaipour, H. R.
    Delea, T. E.
    CURRENT ONCOLOGY, 2016, 23 (04) : E340 - E354
  • [4] COST-EFFECTIVENESS OF PAZOPANIB COMPARED TO SUNITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA
    Fouad, A.
    Atia, A.
    Omar, Y.
    Shawky, M.
    Sakr, M.
    VALUE IN HEALTH, 2016, 19 (07) : A733 - A734
  • [5] Pazopanib or sunitinib for metastatic renal-cell carcinoma?
    Bennet, Neil
    LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
  • [6] Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom
    Amdahl, Jordan
    Diaz, Jose
    Sharma, Arati
    Park, Jinhee
    Chandiwana, David
    Delea, Thomas E.
    PLOS ONE, 2017, 12 (06):
  • [7] Evaluation of the effectiveness and tolerability of sunitinib and pazopanib in the first line treatment of metastatic renal cell carcinoma
    Ebinc, Senar
    Kalkan, Ziya
    Oruc, Zeynep
    Urakci, Zuhat
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Isikdogan, Abdurrahman
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (04): : 226 - 234
  • [8] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
  • [9] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Ronald M. Bukowski
    Current Oncology Reports, 2010, 12 : 77 - 79
  • [10] Efficacy and safety of Pazopanib in the treatment of metastatic renal cell carcinoma
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 572 - 572